EmGenisys

EmGenisys, Inc. is an animal health technology company founded in 2020 by Dr. Cara Wells and Dr. Russell Killingsworth. The company directs its efforts toward improving the efficiency of livestock production through assisted reproductive techniques. Dr. Wells, the CEO, holds a Ph.D. in Animal Science from Texas Tech University and her background in both animal and human clinical IVF laboratories sparked the idea for the company. Dr. Killingsworth, the Chief Veterinary Officer, is a veterinarian with nearly four decades of experience in bovine reproduction.

The company's core business revolves around its flagship product, EmVision, a Software-as-a-Service (SaaS) platform that provides objective, non-invasive analysis of embryo health for the livestock industry. Serving veterinarians, embryologists, and cattle producers in the beef and dairy sectors, EmGenisys aims to increase pregnancy success rates from in-vitro fertilization (IVF) and embryo transfer (ET) procedures. The business model is subscription-based, where users gain access to the analysis platform.

The EmVision technology uses machine learning and computer vision to analyze short, 30-second videos of embryos captured via a smartphone mounted on a standard microscope. The platform assesses the morphokinetic activity frame-by-frame, identifying subtle cellular movements invisible to the human eye, to generate a real-time health and viability score. This data-driven report allows practitioners to select the most viable embryos for transfer, potentially improving pregnancy outcomes by up to 20%. One of the key features is its ability to predict the sex of bovine embryos from the same real-time video analysis. The system is designed for practical on-farm or in-lab use, requiring just a camera-enabled device and an internet connection.

Since its founding, EmGenisys has secured 15 U.S. patents for its technology and has participated in several accelerator programs, including the Texas Tech University Innovation Hub, Creative Destruction Lab, and Luminate. The company has received numerous awards, such as the Farm Bureau Ag Innovation Challenge, Grow NY Food and Agricultural Competition, and the BioTools Innovator Award. In July 2025, EmGenisys announced the close of an oversubscribed $1.5 million seed funding round led by Grit Road Partners, with participation from Tall Grass Ventures and Ag Venture Alliance, to support the global scaling of EmVision and expansion into other livestock species.

Keywords: AgTech, livestock reproduction, embryo analysis, machine learning, computer vision, bovine genetics, SaaS, assisted reproductive technology, IVF efficiency, animal health